Houston, TEXAS3 Active Studies

Chronic Myeloid Leukemia Clinical Trials in Houston, TEXAS

Find 3 actively recruiting chronic myeloid leukemia clinical trials in Houston, TEXAS. Connect with local research sites and explore new treatment options.

3
Active Trials
2
Sponsors
491
Enrolling

Recruiting Chronic Myeloid Leukemia Studies in Houston

About Chronic Myeloid Leukemia Clinical Trials in Houston

Chronic myeloid leukemia (CML) is a type of cancer that starts in blood-forming cells of the bone marrow, characterized by the Philadelphia chromosome and BCR-ABL fusion gene. It was one of the first cancers treated successfully with targeted therapy. Tyrosine kinase inhibitors like imatinib have transformed CML into a manageable chronic condition.

There are currently 3 chronic myeloid leukemia clinical trials recruiting participants in Houston, TEXAS. These studies are seeking a combined 491 participants. Research is being sponsored by Novartis Pharmaceuticals, Baylor College of Medicine. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Myeloid Leukemia Clinical Trials in Houston — FAQ

Are there chronic myeloid leukemia clinical trials in Houston?

Yes, there are 3 chronic myeloid leukemia clinical trials currently recruiting in Houston, TEXAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Houston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you about next steps.

Are clinical trials in Houston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houston studies also compensate for your time and travel.

What chronic myeloid leukemia treatments are being tested?

The 3 active trials in Houston are testing new therapies including novel drugs, biologics, and treatment approaches for chronic myeloid leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov